Medicines Substances Companies Statistics

A free, open platform for EU medicines data, based on official EMA data.

Database

Medicines
Substances
Companies

Data Sources

EMA

2026 uMedical - Open Source Project

Imprint
Privacy Policy
Terms
Contact

Infanrix Penta

LapsedHuman

Details

EMA number	EMEA/H/C/000295
ATC code	J07CA12
Authorisation	23 October 2000
Revision	13

Therapeutic indication

Infanrix Penta is indicated for primary and booster vaccination of infants against diphtheria, tetanus, pertussis, hepatitis B and poliomyelitis.

MeSH: Hepatitis B;Tetanus;Immunization;Whooping Cough;Poliomyelitis;Diphtheria

Group: Vaccines

Active substances

hepatitis B surface antigen Diphtheria toxoid tetanus toxoid Bordetella pertussis antigens (pertussis toxoid, filamentous haemagglutinin, pertactin)

Marketing Authorisation Holder

GlaxoSmithKline Biologicals S.A.

Timeline

Filter by authority:

Infanrix Penta authorised

23 Oct 2000

authorisedregulatory

poliovirus (inactivated) (type-1 (Mahoney strain), type-2 (MEF-1 strain), type-3 (Saukett strain))

Infanrix Penta | uMedical